2 Apr 2026
Urinary megalin expression in children with sickle cell nephropathyPublisher sitePediatric Nephrology, Hemoglobinopathies and Related Disorders
Active, last published 2026
In hemoglobinopathies and related disorders
Busayo Gideon
Ologun
Scholar“Research focused on Hemoglobinopathies and Related Disorders and adjacent fields.”
Claim Your Profile2
H-index
6
Citations
Busayo has not officially claimed their profile. If you are Busayo, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
usayo Gideon Ologun is a researcher working on Hemoglobinopathies and Related Disorders. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Busayo's work has been cited 6 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Hemoglobinopathies and Related Disorders×3Neonatal Health and Biochemistry×2
04 · Where I am
Affiliations
Affiliation on published researchEkiti State University, ZambiaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
3 works22 Nov 2025Open access
Drug Induced Acute Dystonic Paediatric Emergency Admissions In A Southwestern Nigerian Tertiary HospitalPublisher siteNigerian Journal of Family Practice, Poisoning and overdose treatments
28 Jul 2023
Diphtheria in two Nigerian Hospitals: What is New and the Implications for Control.PubMed, Diphtheria, Corynebacterium, and Tetanus
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Busayo?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you